Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
双功能抑制剂揭示 NEK2 是淋巴瘤的治疗靶点和致癌通路调节剂
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-23-0299
Mason McCrury #, Kennith Swafford #, Sydnye L Shuttleworth #, Syed Hassan Mehdi, Baku Acharya, Debasmita Saha, Kevin Naceanceno, Stephanie D Byrum, Aaron J Storey, Ying-Zhi Xu, Claire Doshier, Vijay Patel, Ginell R Post, Annick De Loose, Analiz Rodriguez, Leonard D Shultz, Fenghuang Zhan, Donghoon Y
信号转导
肿瘤
淋巴瘤
FCM
IF
IHC-P
WB
NEK2
